| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $209.9M | -13.3% |
| Cost of Revenue | $163.8M | -14.3% |
| Gross Profit | $46.1M | -9.3% |
| R&D Expense | $46.2M | -14.2% |
| SG&A Expense | $45.9M | -4.9% |
| Operating Income | -$46.8M | +15.1% |
| Pre-tax Income | -$42.6M | +21.4% |
| Income Tax | -$978K | -384.3% |
| Net Income | -$41.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.2M | -8.0% |
| Accounts Receivable | $39.6M | +4.4% |
| Inventory | $52.2M | -22.8% |
| Current Assets | $220.6M | -4.4% |
| Total Assets | $306.8M | -6.8% |
| Current Liabilities | $32.8M | -5.0% |
| Total Liabilities | $52.4M | -10.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.1M | +169.4% |
| Capital Expenditures | $5.3M | -75.0% |
| Investing Cash Flow | -$14.1M | +80.5% |
| Financing Cash Flow | -$859K | +34.2% |
| Free Cash Flow | $4.8M | +113.2% |
| +23.7% |
| EPS (Basic) | -$0.90 | +26.8% |
| EPS (Diluted) | -$0.90 | +26.8% |
| Stockholders' Equity |
| $254.4M |
| -6.1% |